Related Experiment Video

Updated: Jul 15, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.2K

Correction to "Hierarchical Microcarriers Loaded with Peptide Dendrimer-Grafted Methotrexate for Rheumatoid Arthritis

Yang Li, Haofang Zhu, Rui Liu

    Small Science
    |April 11, 2025
    PubMed

    Abstract:

    [This corrects the article DOI: 10.1002/smsc.202300097.].

    More Related Videos

    A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
    09:57

    A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

    Published on: December 23, 2016

    8.8K
    Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
    08:43

    Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

    Published on: February 7, 2018

    7.5K

    Related Experiment Videos

    Last Updated: Jul 15, 2026

    Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
    07:32

    Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

    Published on: August 28, 2015

    11.2K
    A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
    09:57

    A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

    Published on: December 23, 2016

    8.8K
    Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
    08:43

    Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

    Published on: February 7, 2018

    7.5K

    Related Concept Videos

    Modified-Release Drug Delivery Systems: Site-Targeted01:24

    Modified-Release Drug Delivery Systems: Site-Targeted

    Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
    Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

    Site-Targeted Drug Delivery Systems: Polymeric Carriers

    Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

    Articles linked to this work by shared authors, journal, and citation graph.

    Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies.

    Frontiers in immunology·2026

    Co-recorded conditions in ischemic and hemorrhagic stroke: a 20-year national analysis of 598,186 natural deaths with machine learning.

    Frontiers in neurology·2026

    Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis.

    Arthritis & rheumatology (Hoboken, N.J.)·2026

    Disease-specific heterogeneity of C-reactive protein across 21 hematologic disorders reflects divergent inflammatory and hematopoietic phenotypes.

    Frontiers in immunology·2026

    A real-world, triple-cohort study on the effectiveness and safety of telitacicept in immunosuppressant-naïve and refractory lupus nephritis.

    Frontiers in immunology·2026

    Combined Application of a Composite Microbial Inoculant and Bulking Agents Improves Chicken Manure Composting.

    Microorganisms·2026

    Additive Manufacturing Engineering for Electrochemistry: Conductive High-Density Polyethylene Filament Expands the Materials Landscape.

    Small science·2026

    Electrochemical Investigation of Compatibility Between Chloride- and Sulfide-Based Solid Electrolytes Using Four-Electrode Cells.

    Small science·2026

    3D DLP Fabrication of Electrically Conductive Polypyrrole Nanocomposites.

    Small science·2026

    [60]Fullerene-Cluster Hybrids as Boron-Dense Delivery Nanoplatforms.

    Small science·2026

    Unveiling Search-Robust One-Shot Learning Operation in FeTFT-Based Ternary Content-Addressable Memory.

    Small science·2026

    Visualizing Reversible Uranyl (UO2 2+) Capture and Release With Self-Indicating Porous Organic Polymers.

    Small science·2026

    Mechanical circulatory support devices in heart failure: a narrative review of current evidence, clinical applications, complications, and future directions.

    Frontiers in cardiovascular medicine·2026

    Efficacy and safety of ultrasound-guided microwave "Near-Total Ablation" for refractory hyperthyroidism: a retrospective study.

    Frontiers in endocrinology·2026

    Pharmacotherapy for MASLD/MASH: approved therapies, drug repurposing, and emerging mechanism-based candidates.

    Expert opinion on pharmacotherapy·2026

    Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026

    Long-term outcomes of alemtuzumab in relapsing-remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab.

    Journal of the neurological sciences·2026

    Germline DDX41 defines a distinct subgroup in MDS undergoing transplantation with reduced relapse and improved survival.

    Blood·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us